| Assay ID | Title | Year | Journal | Article |
|---|
| AID1745847 | CMV-Luciferase Counterscreen for Inhibitors of ATXN expression | | | |
| AID1745849 | Viability Counterscreen for CMV-Luciferase Assay of Inhibitors of ATXN expression | | | |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1745848 | Confirmatory qHTS for Inhibitors of ATXN expression | | | |
| AID1745850 | Viability Counterscreen for Confirmatory qHTS for Inhibitors of ATXN expression | | | |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1745846 | Firefly Luciferase Counterscreen for Inhibitors of ATXN expression | | | |
| AID1581704 | Selectivity index, ratio of IC50 for human recombinant CYP1A2 to IC50 for human recombinant CYP1B1 using 7-ethoxyresorufin as substrate in presence of glucose-6-phosphate, glucose-6-phosphate dehydrogenase and NADPH-generating system by fluorometry | 2020 | European journal of medicinal chemistry, Feb-01, Volume: 187 | Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors. |
| AID1581703 | Selectivity index, ratio of IC50 for human recombinant CYP1A1 to IC50 for human recombinant CYP1B1 using 7-ethoxyresorufin as substrate in presence of glucose-6-phosphate, glucose-6-phosphate dehydrogenase and NADPH-generating system by fluorometry | 2020 | European journal of medicinal chemistry, Feb-01, Volume: 187 | Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors. |
| AID340771 | Agonist activity at CFTR-deltaF508 mutant expressed in NIH3T3 cells assessed as increase in forskolin-stimulated current at 20 uM by whole cell assay relative to control | 2008 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
| Activation of CFTR by UCCF-029 and genistein. |
| AID1581702 | Inhibition of human recombinant CYP1A2 using 7-ethoxyresorufin as substrate in presence of glucose-6-phosphate, glucose-6-phosphate dehydrogenase and NADPH-generating system incubated for 50 mins by fluorometry | 2020 | European journal of medicinal chemistry, Feb-01, Volume: 187 | Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors. |
| AID340528 | Agonist activity at CFTR-deltaF508 mutant expressed in NIH3T3 cells assessed as increase in forskolin-stimulated current | 2008 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
| Activation of CFTR by UCCF-029 and genistein. |
| AID1581701 | Inhibition of human recombinant CYP1A1 using 7-ethoxyresorufin as substrate in presence of glucose-6-phosphate, glucose-6-phosphate dehydrogenase and NADPH-generating system incubated for 15 mins by fluorometry | 2020 | European journal of medicinal chemistry, Feb-01, Volume: 187 | Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors. |
| AID340532 | Agonist activity at CFTR-K1250A mutant assessed as increase in forskolin-stimulated current at 5 uM | 2008 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
| Activation of CFTR by UCCF-029 and genistein. |
| AID241691 | Inhibition of DNA dependent protein kinase isolated from HeLa cells | 2005 | Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
| Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro. |
| AID340529 | Agonist activity at CFTR-deltaF508 mutant expressed in NIH3T3 cells assessed as increase in forskolin-stimulated current at 30 uM by whole cell assay relative to control | 2008 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
| Activation of CFTR by UCCF-029 and genistein. |
| AID1581700 | Inhibition of human recombinant CYP1B1 using 7-ethoxyresorufin as substrate in presence of glucose-6-phosphate, glucose-6-phosphate dehydrogenase and NADPH-generating system incubated for 35 mins by fluorometry | 2020 | European journal of medicinal chemistry, Feb-01, Volume: 187 | Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors. |
| AID340530 | Agonist activity at CFTR-deltaF508 mutant expressed in NIH3T3 cells assessed as increase in forskolin-stimulated current at 30 uM by whole cell assay relative to genistein | 2008 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
| Activation of CFTR by UCCF-029 and genistein. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |